M C Cummings

Summary

Affiliation: University of Queensland
Country: Australia

Publications

  1. ncbi Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis
    M C Cummings
    Department of Pathology, University of Queensland, Royal Brisbane Hospital Research Foundation, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Am J Surg Pathol 26:1286-95. 2002
  2. ncbi Occult axillary node metastases in breast cancer: their detection and prognostic significance
    M A McGuckin
    Department of Obstetrics and Gynaecology, University of Queensland, Royal Brisbane Hospital, Herston, Australia
    Br J Cancer 73:88-95. 1996
  3. ncbi Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro
    M D Walsh
    Department of Pathology, University of Queensland Medical School, Herston, Australia
    Breast Cancer Res Treat 58:255-66. 1999
  4. ncbi Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways
    J R Jass
    Department of Pathology, University of Queensland Medical School, Herston, Australia
    J Clin Pathol 52:455-60. 1999
  5. ncbi Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer
    P M Webb
    Department of Social and Preventive Medicine, University of Queensland, Brisbane, Australia
    J Natl Cancer Inst 90:1729-34. 1998
  6. ncbi Changes in survival after breast cancer: improvements in diagnosis or treatment?
    P M Webb
    Queensland Institute of Medical Research, Royal Brisbane Hospital, Brisbane, Queensland, Australia
    Breast 13:7-14. 2004
  7. ncbi Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis
    M C Cummings
    Department of Pathology, University of Queensland Medical School, Herston, Australia
    Br J Cancer 82:1204-10. 2000
  8. ncbi Breast fine needle aspiration cytology: a review of current practice in Australasia
    M C Cummings
    RCPA Cytopathology QAP, University of Queensland Centre for Clinical Research, Royal Brisbane and Women s Hospital, Herston, Queensland, Australia
    Cytopathology 22:269-75. 2011
  9. ncbi Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy
    A R Clarke
    CRC Laboratories, Department of Pathology, University Medical School, Edinburgh, UK
    Oncogene 11:1913-20. 1995

Collaborators

Detail Information

Publications9

  1. ncbi Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis
    M C Cummings
    Department of Pathology, University of Queensland, Royal Brisbane Hospital Research Foundation, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Am J Surg Pathol 26:1286-95. 2002
    ..The presence of occult metastases approached significance for overall survival in the premenopausal and perimenopausal patients but not in the postmenopausal patients...
  2. ncbi Occult axillary node metastases in breast cancer: their detection and prognostic significance
    M A McGuckin
    Department of Obstetrics and Gynaecology, University of Queensland, Royal Brisbane Hospital, Herston, Australia
    Br J Cancer 73:88-95. 1996
    ..However there was not a significant independent association of the presence of occult metastases with overall survival (P = 0.11). These findings have important implications with regard to selection of ANN patients for adjuvant therapy...
  3. ncbi Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro
    M D Walsh
    Department of Pathology, University of Queensland Medical School, Herston, Australia
    Breast Cancer Res Treat 58:255-66. 1999
    ..Although we showed no correlation between tumorigenicity or metastasis and MUC1 expression, this study will assist development of experimental models to assess the influence of MUC1 of on breast cancer progression...
  4. ncbi Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways
    J R Jass
    Department of Pathology, University of Queensland Medical School, Herston, Australia
    J Clin Pathol 52:455-60. 1999
    ....
  5. ncbi Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer
    P M Webb
    Department of Social and Preventive Medicine, University of Queensland, Brisbane, Australia
    J Natl Cancer Inst 90:1729-34. 1998
    ..We have further investigated the association between ovulatory history and p53 gene mutation by use of data from a large case-control study of ovarian cancer in Australia...
  6. ncbi Changes in survival after breast cancer: improvements in diagnosis or treatment?
    P M Webb
    Queensland Institute of Medical Research, Royal Brisbane Hospital, Brisbane, Queensland, Australia
    Breast 13:7-14. 2004
    ..75; 95% CI 0.56-1.01) and disease-free survival (HR 0.72; 0.56-0.92) at 5 years. This suggests that both earlier diagnosis and changes in breast cancer treatment have contributed to improved breast cancer survival...
  7. ncbi Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis
    M C Cummings
    Department of Pathology, University of Queensland Medical School, Herston, Australia
    Br J Cancer 82:1204-10. 2000
    ....
  8. ncbi Breast fine needle aspiration cytology: a review of current practice in Australasia
    M C Cummings
    RCPA Cytopathology QAP, University of Queensland Centre for Clinical Research, Royal Brisbane and Women s Hospital, Herston, Queensland, Australia
    Cytopathology 22:269-75. 2011
    ..To investigate breast fine needle aspiration (FNA) cytology in Australasia, in terms of laboratory demographics, specimens received and quality control (QC)...
  9. ncbi Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy
    A R Clarke
    CRC Laboratories, Department of Pathology, University Medical School, Edinburgh, UK
    Oncogene 11:1913-20. 1995
    ..These findings highlight striking tissue-specific differences in the tumor suppressor effects of p53...